Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
November 29, 2023

Evommune, Accutar to discover drug candidates for chronic inflammatory diseases

Evommune has entered into a new strategic partnership with Accutar Biotechnology to discover new small-molecule drug candidates for chronic inflammatory diseases.

The partnership will focus on the development of next-generation therapies. Credit: Lucas Vasques on Unsplash.